NCT07755202
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07755202 |
| Title | Gilteritinib-Azacitidine-Venetoclax Combination Therapy in Patients With Relapsed/Refractory Leukemia (GAVE001) |
| Acronym | GAVE001 |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Florian Kuchenbauer |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | CAN |
CKB BOOST